The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
telephone:
01413305082
email:
Annette.Lake@glasgow.ac.uk
Centre for Virus Research, Room 204, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow, G61 1QH
Member of the Jarrett Group.
Berndt, S. I. et al. (2022) Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia, 36(12), pp. 2835-2844. (doi: 10.1038/s41375-022-01711-0) (PMID:36273105)
Rinaldi, C., Corrigan, D. K., Dennany, L., Jarrett, R. F. , Lake, A. and Baker, M. J. (2021) Development of an electrochemical CCL17/TARC biosensor toward rapid triage and monitoring of classic Hodgkin lymphoma. ACS Sensors, 6(9), pp. 3262-3272. (doi: 10.1021/acssensors.1c00972) (PMID:34478275)
Liu, Z. et al. (2020) Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma. International Journal of Cancer, 147(3), pp. 608-618. (doi: 10.1002/ijc.32741) (PMID:31618442)
Sud, A. et al. (2017) Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nature Communications, 8, 1892. (doi: 10.1038/s41467-017-00320-1) (PMID:29196614) (PMCID:PMC5711884)
Johnson, P. C.D. et al. (2015) Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. International Journal of Cancer, 137(5), pp. 1066-1075. (doi: 10.1002/ijc.29467) (PMID:25648508) (PMCID:PMC4737225)
Bell, A. J., Gallagher, A., Mottram, T., Lake, A., Kane, E. V., Lightfoot, T., Roman, E. and Jarrett, R. F. (2014) Germ-line transmitted, chromosomally integrated hhv-6 and classical Hodgkin lymphoma. PLoS ONE, 9(11), e112642. (doi: 10.1371/journal.pone.0112642) (PMID:25384040) (PMCID:PMC4226568)
Frampton, M. et al. (2013) Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin’s lymphoma. Nature Communications, 4, (doi: 10.1038/ncomms3549)
Urayama, K. Y. et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. Journal of the National Cancer Institute, 104(3), pp. 240-253. (doi: 10.1093/jnci/djr516)
Enciso-Mora, V. et al. (2010) A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nature Genetics, 42(12), pp. 1126-1130. (doi: 10.1038/ng.696)
Hjalgrim, H. et al. (2010) HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 107(14), pp. 6400-6405. (doi: 10.1073/pnas.0915054107)
Lake, A. et al. (2009) Mutations of NFKBIA, encoding I kappa B alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. International Journal of Cancer, 125(6), pp. 1334-1342. (doi: 10.1002/ijc.24502)
Berndt, S. I. et al. (2022) Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia, 36(12), pp. 2835-2844. (doi: 10.1038/s41375-022-01711-0) (PMID:36273105)
Rinaldi, C., Corrigan, D. K., Dennany, L., Jarrett, R. F. , Lake, A. and Baker, M. J. (2021) Development of an electrochemical CCL17/TARC biosensor toward rapid triage and monitoring of classic Hodgkin lymphoma. ACS Sensors, 6(9), pp. 3262-3272. (doi: 10.1021/acssensors.1c00972) (PMID:34478275)
Liu, Z. et al. (2020) Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma. International Journal of Cancer, 147(3), pp. 608-618. (doi: 10.1002/ijc.32741) (PMID:31618442)
Sud, A. et al. (2017) Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. Nature Communications, 8, 1892. (doi: 10.1038/s41467-017-00320-1) (PMID:29196614) (PMCID:PMC5711884)
Johnson, P. C.D. et al. (2015) Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. International Journal of Cancer, 137(5), pp. 1066-1075. (doi: 10.1002/ijc.29467) (PMID:25648508) (PMCID:PMC4737225)
Bell, A. J., Gallagher, A., Mottram, T., Lake, A., Kane, E. V., Lightfoot, T., Roman, E. and Jarrett, R. F. (2014) Germ-line transmitted, chromosomally integrated hhv-6 and classical Hodgkin lymphoma. PLoS ONE, 9(11), e112642. (doi: 10.1371/journal.pone.0112642) (PMID:25384040) (PMCID:PMC4226568)
Frampton, M. et al. (2013) Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin’s lymphoma. Nature Communications, 4, (doi: 10.1038/ncomms3549)
Urayama, K. Y. et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. Journal of the National Cancer Institute, 104(3), pp. 240-253. (doi: 10.1093/jnci/djr516)
Enciso-Mora, V. et al. (2010) A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nature Genetics, 42(12), pp. 1126-1130. (doi: 10.1038/ng.696)
Hjalgrim, H. et al. (2010) HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 107(14), pp. 6400-6405. (doi: 10.1073/pnas.0915054107)
Lake, A. et al. (2009) Mutations of NFKBIA, encoding I kappa B alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases. International Journal of Cancer, 125(6), pp. 1334-1342. (doi: 10.1002/ijc.24502)
